Insights^

House Energy and Commerce Discusses Concerns Over FDA’s Regulation of Laboratory Developed Tests (LDTs)

On March 21, 2024, the House Energy and Commerce Health Subcommittee held a hearing on Food and Drug Administration (FDA) regulation of laboratory developed tests (LDTs) and the impact of FDA’s proposed rule on patient access.

Leave a Reply

Your email address will not be published. Required fields are marked *

Connect With Us

Ready to connect? Let’s talk